Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2023-04-25 Governance Information
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
安信证券股份有限公司关于山西大禹生物工程股份有限公司2022年度公司治理专项自查及规范活动之专项核查报告
Governance Information Classification · 95% confidence The document is a detailed report by a sponsoring securities firm on the 2022 annual corporate governance self-inspection and compliance activities of Shanxi Dayu Bioengineering Co., Ltd. It covers internal system construction, organizational setup, board and senior management qualifications and duties, decision-making procedures, governance constraints, and checks on financial and compliance issues such as fund occupation, illegal guarantees, and insider trading. The document is a comprehensive governance review report for the year 2022, not a brief announcement or a certification letter. It does not contain financial statements or earnings data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy statement or voting results announcement. It is not a regulatory filing or a report publication announcement. The content fits the category of Governance Information (CGR), which details the company's internal rules, board structure, and governance practices. The document length is under 5,000 characters but contains substantive governance content, not just an announcement. Therefore, the best classification is CGR with high confidence.
2023-04-25 Chinese
第三届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board meeting of Shanxi Dayu Biological Engineering Co., Ltd. It details the approval of various reports and proposals including the 2022 Supervisory Board Work Report, 2022 Financial Final Report, 2023 Financial Budget Report, 2022 Audit Report, 2022 Annual Report and Summary, 2023 Q1 Report, 2022 Dividend Distribution Plan, and other governance and financial matters. The document is a formal announcement of the meeting decisions and approvals, not the reports themselves. It references that the actual reports are disclosed elsewhere (on the Beijing Stock Exchange information platform). The document length is under 5,000 characters and serves as a meeting resolution announcement rather than the full reports. This fits best with the category of Regulatory Filings (RNS) as it is a general regulatory announcement of meeting resolutions and approvals without containing the full financial data or reports themselves.
2023-04-25 Chinese
2022年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled '2022 年度独立董事述职报告' which translates to '2022 Annual Independent Directors' Report'. It details the independent directors' duties, attendance at board and shareholder meetings, opinions on various board resolutions, supervision activities, and training attended during the year 2022. The content focuses on the independent directors' performance and governance oversight rather than full financial statements or audit results. It is a report on board/management activities specifically related to independent directors' duties and opinions. It does not contain financial statements or audit opinions, so it is not an Annual Report (10-K) or Audit Report (AR). It is not a regulatory filing or announcement but a substantive report on board/management information. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 2843 characters, which is consistent with a detailed report but not a full annual report. Confidence is high given the clear focus on independent directors' duties and opinions.
2023-04-25 Chinese
独立董事关于第三届董事会第八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several proposals discussed at the company's board meeting, including dividend distribution, use of raised funds, auditor reappointment, and remuneration plans for management and directors. It is dated April 26, 2023, and relates to the 2022 fiscal year and 2023 plans. The content is a formal opinion statement from independent directors rather than a full report or announcement of voting results. It does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is a governance-related document expressing independent directors' views on board matters and proposals to be submitted to the shareholders' meeting. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1404 characters), and it is not merely an announcement or certification but an opinion statement from board members.
2023-04-25 Chinese
2022 年年度权益分派预案公告
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the company's 2022 annual profit distribution plan, including cash dividends and stock dividends, with references to the audited 2022 annual report. It includes the board of directors' approval, independent directors' opinions, supervisory board opinions, and detailed explanations of the profit distribution policy and procedures. The document is not the annual report itself but an announcement of the dividend distribution plan based on the annual report. It is a formal announcement of dividend amounts and related shareholder information, fitting the definition of a Notice of Dividend Amount (DIV). The document length is 4069 characters, which is sufficient for a detailed dividend announcement but does not contain full financial statements or comprehensive annual report content. Therefore, the correct classification is Notice of Dividend Amount (DIV).
2023-04-25 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2022 年度内部控制自我评价报告' which translates to '2022 Annual Internal Control Self-Evaluation Report'. It is issued by the company's board and discusses the evaluation of internal control related to financial reporting as of December 31, 2022. The content includes detailed descriptions of the company's internal control environment, risk assessments, control activities, and defect identification and remediation related to internal controls. It is a standalone report focused on internal control evaluation rather than a full annual report or audit report. The document length is 8333 characters, which is substantial and contains detailed substantive content, not just an announcement or certification. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations related to financial reporting but excludes full annual reports. Therefore, the appropriate classification is AR with high confidence. FY 2022
2023-04-25 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.